Ultragenyx Pharmaceutical
RARE
#3251
Rank
C$5.03 B
Marketcap
$52.11
Share price
-4.26%
Change (1 day)
-17.95%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) - Cash on Hand

Cash on Hand as of December 2024 : C$0.87 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company has C$0.87 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ultragenyx Pharmaceutical - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.87 B14.34%
2023-12-31C$0.76 B-24.55%
2022-12-31C$1.01 B7.56%
2021-12-31C$0.94 B-38.43%
2020-12-31C$1.53 B55.32%
2019-12-31C$0.98 B57.51%
2018-12-31C$0.62 B112.41%
2017-12-31C$0.29 B-42.29%
2016-12-31C$0.51 B-15.73%
2015-12-31C$0.60 B178.62%
2014-12-31C$0.21 B282.92%
2013-12-31C$56.81 M-33.7%
2012-12-31C$85.7 M691.53%
2011-12-31C$10.82 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.63 B 86.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.35 B-59.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.20 B-76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.34 B-60.99%๐Ÿ‡บ๐Ÿ‡ธ USA